Home›Stock Screener›GKB Ophthalmics

GKB Ophthalmics Share Price Today | Stock Price & GKB Ophthalmics Share Screener

GKB Healthcare Equipment & Supplies
Live Share Price NSE
₹59.27
▼ -1.37 (-2.26%)
2026-11-18 00:00:00
Live Share Price BSE
₹61.71
▼ -1.88 (-2.96%)
2026-11-18 00:00:00

As of November 18, 2026, the live GKB Ophthalmics share price (NSE: GKB) is ₹59.27 on NSE and ₹61.71 on BSE, down 2.26% from the previous close, with shares trading between ₹58.86 and ₹60.50 in today's trading session, and a 52-week range of ₹58.30–₹71.52. Track GKB company valuation to gauge the company's total market size. Use the GKB Ophthalmics stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today GKB Ophthalmics opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹33 and net income of ₹1, with EBITDA of ₹3, an operating margin of 8.0% and a profit margin of 3.0%.

GKB Ophthalmics Market Cap ₹30.70 Cr.
GKB P/E Ratio (TTM) 6.60
GKB Ophthalmics P/B Ratio 0.59
EPS (TTM) ₹-7.08
Dividend Yield -
Debt to Equity 0.25
GKB 52 Week High ₹71.52
GKB Ophthalmics 52 Week Low ₹58.30
Operating Margin 8.00%
Profit Margin 3.03%
GKB Revenue (TTM) ₹33.00
EBITDA ₹3.00
Net Income ₹1.00
Total Assets ₹132.00
Total Equity ₹55.00

GKB Ophthalmics Share Price Chart

Track the current stock price of GKB Ophthalmics with an interactive chart. Analyse GKB share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete GKB Ophthalmics stock quote in one place.

The quote of ₹59.27 sits between the 52-week low of ₹58.30 and the 52-week high of ₹71.52, and the latest session moved -2.26% from the previous close.

GKB Ophthalmics Company Profile - Fundamental Screener

Screen GKB Ophthalmics company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GKB shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Equipment & Supplies industry, and it trades under ISIN INE265D01015.

Company Details

Classification

Sector Healthcare
Industry Healthcare Equipment & Supplies
Sub-Sector Healthcare Equipment & Supplies
Segment E

Identifiers and Leadership

ISIN INE265D01015

GKB Ophthalmics Balance Sheet Screener

Screen GKB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹132, up from ₹125 in 2025.

Latest statistics put total assets at ₹132 and shareholder funds at ₹55, with a leverage ratio of 0.25.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 132 125 115 112 110 107 102 93 83 82
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 15 17 18 19 23 24 26 26 18 18

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 6 6 4 4 4 2 2 2 2 2
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 55 56 64 67 67 66 59 55 45 47
Share Capital 5 5 5 5 5 5 5 5 4 4
Reserves & Surplus 48 47 55 58 58 58 54 47 41 43

GKB Ophthalmics Income Statement Screener - Profit & Revenue Analysis

Screen GKB Ophthalmics income statement and profit fundamentals. Analyze GKB quarterly results. GKB Ophthalmics reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹33 and net profit was ₹1, equal to earnings per unit of ₹1.31, at an operating margin of 8%.

In that period expenses were ₹30, interest cost ₹0 and tax ₹1. The next period listed, 2026-Jun, shows revenue of ₹34 and net profit of ₹2.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar

Revenue and Expenses

Revenue 33 34 31 58 31 33 31 26 26 26 22 24 21 23 20
Expenses 30 30 28 55 27 32 34 27 26 25 22 25 21 21 20

Operating Costs and Margins

EBITDA 3 3 2 2 3 1 -3 -1 0 1 1 0 0 2 0
Operating Profit % 8.00% 8.00% 5.00% 2.00% 10.00% 2.00% -9.00% -4.00% 0.00% 4.00% 0.00% -3.00% -1.00% 6.00% -2.00%
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2
Interest 0 1 1 1 1 1 1 1 1 1 1 0 1 0 0

Profit and Earnings

Profit Before Tax 2 2 1 1 2 -1 -4 -2 -1 0 -1 -1 -1 1 -2
Tax 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 1 2 1 1 2 -1 -4 -2 -1 0 -1 -1 -1 1 -2
EPS 1.31 2.00 0.38 0.08 3.17 -2.02 -7.03 -4.03 -2.41 -0.50 -1.81 -2.48 -2.32 1.04 -3.80

GKB Ophthalmics Cash Flow Screener - Liquidity Fundamentals

Screen GKB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹4.

Over the same period, investing activities provided ₹9 and financing activities used ₹6.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities -4 -3 4 -3 5 7 3 4 -3 -3
Investing Activities 9 3 -2 1 -4 -17 -4 -10 1 4

Financing and Net Cash

Financing Activities -6 1 -2 -2 -2 3 4 13 1 -1
Net Cash Flow 0 0 1 -4 0 -7 4 7 0 -1

GKB Ophthalmics Shareholding Pattern Screener

See GKB Ophthalmics shareholding pattern with promoter, FII, and DII holdings. Check GKB Ophthalmics promoter holding and ownership changes for GKB on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 51.13%, foreign institutions 1.79%, domestic institutions 0.00% and the public 38.52%, spread across 2,634 shareholders.

The shareholder count was 2,634 in 2026-Mar, compared with 2,557 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 51.13% 51.15% 51.15% 50.99% 51.06% 51.06% 51.13% 50.93%

Institutional Investors

FII Holding 1.79% 1.79% 1.79% 1.79% 1.79% 1.79% 1.79% 1.79%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 38.52% 38.97% 39.87% 37.36% 37.22% 37.23% 38.55% 36.04%
Other Holding 8.57% 8.09% 7.20% 9.87% 9.94% 9.93% 8.53% 11.23%
Shareholder Count 2,634 2,557 2,633 2,538 2,550 2,601 2,661 2,370

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by GKB Ophthalmics. GKB Ophthalmics dividend yield can be compared with peers and other stocks in the market.

No dividends declared by GKB Ophthalmics.

GKB Ophthalmics Stock Index Membership - Nifty & Sensex

See which indices include GKB Ophthalmics stock. Check GKB index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

GKB Ophthalmics is not part of any tracked indices.
Only major market indices are tracked in our system.

GKB Ophthalmics Market Events Screener - Corporate Actions

Get GKB Ophthalmics corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check GKB Ophthalmics stock events that may affect GKB share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 12, 2026, with a record date of November 12, 2026.

It is followed by Annual General Meeting dated September 25, 2026 and Annual General Meeting dated August 25, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-12 2026-11-12 Quarterly Result Announcement NA 3.80%
2026-09-25 2026-09-25 Annual General Meeting NA -1.43%
2026-08-25 2026-08-25 Annual General Meeting NA 13.45%
2026-08-12 2026-08-12 Quarterly Result Announcement NA 4.35%
2026-05-27 2026-05-27 Quarterly Result Announcement NA -0.93%
2026-02-12 2026-02-12 Quarterly Result Announcement NA 0.63%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -11.47%
2025-08-21 2025-08-21 Annual General Meeting NA 9.47%
2025-08-14 2025-08-14 Quarterly Result Announcement NA -1.78%
2025-05-30 2025-05-30 Quarterly Result Announcement NA 4.58%
2025-02-13 2025-02-13 Quarterly Result Announcement NA -1.18%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -1.14%
2024-08-20 2024-08-20 Annual General Meeting NA 24.77%

GKB Ophthalmics Competitors Screener - Peer Stocks Comparison

Screen GKB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Molbio Diagnostics 17,129 121.60 1,455 41.57% 164 60.75
Poly Medicure 17,072 53.80 1,995 13.43% 321 64.63
Sahajanand Medical Technologies 5,522 78.70 1,219 17.64% 69 75.49
Tarsons Products 1,651 226.00 447 9.38% 14 47.58
Laxmi Dental 1,099 34.60 286 18.15% 26 57.90
Q-Line Biotech 1,026 20.40 347 7.89% 56 30.31
Hemant Surgical Industries 936 51.00 238 112.99% 18 63.65
Vasa Denticity 846 69.90 283 12.77% 10 65.05
Osel Devices 656 23.40 295 57.88% 29 50.35
Fabtech Technologies 609 17.50 431 28.40% 38 53.39

GKB Ophthalmics Company Announcements - News & Reports Screener

Screen GKB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 17, 2026.

The next most recent announcements are dated November 15, 2026 and November 15, 2026.

Date Update Actions
2026-11-17 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-15 Financial Results Of The Company For The Quarter And Half Year Ended September 30 2026. -
2026-11-15 Board Meeting Outcome for Outcome Of The Board Meeting Held On November 12 2026. -
2026-10-29 Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026 -
2026-10-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-28 Closure of Trading Window -
2026-09-22 Submission Of Minutes Of 44Th Annual General Meeting Of The Company Held On 25Th August 2026. -
2026-08-26 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-25 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-12 Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026. -
2026-08-12 Board Meeting Outcome for Outcome Of The Board Meeting Of GKB Ophthalmics Ltd. Held On August 12 2026 -
2026-08-01 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-31 Disclosure Of Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015("Listing Regulations) -
2026-07-31 Notice For Book Closure -
2026-07-31 Reg. 34 (1) Annual Report. -
2026-07-25 Board Meeting Intimation for Approval Of Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026 -
2026-07-14 Disclosure Of Information Pursuant To Regulation 30- Update On Case No. 32/09 Filed For Adjudication Of Charter Of Demands -
2026-07-07 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-30 Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹59.27, within a 52-week range of ₹58.30 to ₹71.52. The P/E ratio is 6.60 and the P/B ratio is 0.59, with earnings per unit of ₹-7.08. Market capitalisation stands at ₹30.70 Cr. The company operates in the Healthcare sector, in the Healthcare Equipment & Supplies industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 19, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.